Table 1.
Patients and controls demographics
| Patients (Total=61) |
Normal database (Total=120) |
Healthy test group (Total=35) |
Disease test group (Total=16) |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SAHZU Total=11 |
BTH Total=16 |
CCF Total=34 |
SAHZU Total=22 |
CCF Total=24 |
PING study Total=74 |
CCF Total=13 |
PING Total=22 |
SAHZU Total=4 |
CCF Total=11 |
|
| Male, N(%) | 3(27.3%) | 10 (62.5%) | 19(55.9%) | 11(50%) | 11(45.8%) | 32(43.2%) | 7 (53.8%) | 10(45.5%) | 2 (50.0%) | 5 (45.4%) |
| Age at MRI scan, year | 20.3 (5–23) | 20.5 (5–36) | 20.7 (5–58) | 34.5 (23–49) | 27.3 (23–40) | 13.8 (5–21) | 36.5 (25–42) | 13.8 (5–21) | 38.0 (25–51) | 36.1 (15–55) |
| Children (age ≤18 years) | 7(63.6%) | 9(56.3%) | 17(50%) | 0 | 0 | 51 | 0 | 14 | ||
| Age at onset, year | 6.8 (0.17–19) | 6.90 (0.42–12) | 6.45 (0.5–35) | – | – | – | – | – | 17 (13–19) | 13.5 (1–48) |
| Epilepsy duration, month | 163.9 (12–204) | 167.4 (12–324) | 165.8 (24–540) | – | – | – | – | – | 252 (144–384) | 272.7 (84–516) |
| MRI scanners (all 3T) | GE discovery MR750 | Siemens Verio | Siemens Trio | GE discovery MR750 | Siemens Trio | GE discovery MR750(12); GE Signa HDX(15); Siemens Trio(39); Phillips Achieva(8) | Siemens Trio | GE discovery MR750 (1); GE Signa HDX(4); Siemens Trio (12); Phillips Achieva(5) | GE discovery MR750 | Siemens Trio |
PING: Pediatric Imaging, Neurocognition, and Genetics.